Ratiopharm
![]() | This article needs additional citations for verification. (March 2010) |
![]() | |
Type | Private |
---|---|
Industry | Pharmaceutical industry |
Founded | 1974 |
Founders | Merckle family |
Headquarters | Ulm, Germany |
Key people | Adolf Merckle, founder Oliver Windholz, CEO |
Products | Pharmaceuticals and generic medication. |
Revenue | ![]() |
Number of employees | 5,417 (2007) |
Parent | Teva Pharmaceutical Industries |
Website | Ratiopharm.com |
![12-08-18-tilidin-retard.jpg](http://upload.wikimedia.org/wikipedia/commons/thumb/6/65/12-08-18-tilidin-retard.jpg/220px-12-08-18-tilidin-retard.jpg)
Ratiopharm is a German pharmaceutical company that is Europe's leading generics brand.
Ratiopharm was owned by Adolf Merckle and makes generic pharmaceuticals. They are based in Ulm, Germany, and products being distributed[clarification needed] in over 35 countries worldwide.
On March 18, 2010, Teva announced that it planned to acquire Ratiopharm for US$5 billion.[1][2] On August 10, 2010, Teva announced that it had completed its acquisition of Ratiopharm.[3]
See also[]
References[]
- ^ NATASHA SINGER (March 18, 2010). "Teva to Acquire Top German Generics Maker for $5 Billion". The New York Times. Retrieved March 18, 2010.
- ^ Teva to Acquire Generics Firm The Wall Street Journal March 19, 2010
- ^ "Teva Completes Acquisition of Ratiopharm". August 10, 2010. Archived from the original on August 18, 2010. Retrieved August 20, 2010.
External links[]
Categories:
- Pharmaceutical companies of Germany
- Companies based in Ulm
- Pharmaceutical companies established in 1974
- Medical and health organisations based in Baden-Württemberg
- German company stubs